Merrimack Pharmaceuticals Stock Target Price and Analyst Consensus
| MACK Stock | USD 14.73 0.01 0.07% |
The current analyst and expert consensus on Merrimack Pharmaceuticals is Strong Sell, with no strong buy opinions. The current projected Merrimack Pharmaceuticals target price consensus is 4.00 with 0 analyst opinions. The most common way Merrimack Pharmaceuticals analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview Merrimack Pharmaceuticals executives and customers to further validate their buy or sell advice. Please note, the number of analysts providing the opinion is not sufficient to provide adequate consensus on Merrimack Pharmaceuticals. We encourage you to use your own analysis of Merrimack Pharmaceuticals to validate this buy or sell advice. Merrimack Pharmaceuticals buy-or-sell recommendation module provides average expert sentiment on the projected Merrimack Pharmaceuticals target price to derive its highest and lowest estimates based on its projected price volatility. Check out Macroaxis Advice on Merrimack Pharmaceuticals to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. For more information on how to buy Merrimack Stock please use our How to buy in Merrimack Stock guide.
Lowest Forecast 3.64 | Highest Forecast 4.44 | Target Price 4 |
Merrimack |
It's important to approach Merrimack Pharmaceuticals' target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.
Steps to utilize Merrimack Pharmaceuticals price targets
Merrimack Pharmaceuticals' stock target price is an estimate of its future price, usually made by analysts. Using Merrimack Pharmaceuticals' target price to determine if it is a suitable investment can be done through the following steps:- Look at Merrimack Pharmaceuticals' target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
- Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
- Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
- Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Merrimack Pharmaceuticals' stock is likely to perform well.
- Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Additional Merrimack Pharmaceuticals Value Projection Modules
Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Merrimack Pharmaceuticals is a key component of Merrimack Pharmaceuticals valuation and have some predictive power on the future returns of a Merrimack Pharmaceuticals.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Merrimack Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Impulse Invested over 100 shares | |
 | Hedge Favorites Invested over 60 shares | |
 | Macroaxis Index Invested few shares | |
 | Momentum Invested over 40 shares | |
 | Banking Invested over 40 shares | |
 | Manufacturing Invested over 40 shares | |
 | Blockchain Invested few shares | |
 | Synthetics Invested over 100 shares | |
 | Chemicals Makers Invested over 500 shares |
Check out Macroaxis Advice on Merrimack Pharmaceuticals to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. For more information on how to buy Merrimack Stock please use our How to buy in Merrimack Stock guide.Note that the Merrimack Pharmaceuticals information on this page should be used as a complementary analysis to other Merrimack Pharmaceuticals' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Complementary Tools for Merrimack Stock analysis
When running Merrimack Pharmaceuticals' price analysis, check to measure Merrimack Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Merrimack Pharmaceuticals is operating at the current time. Most of Merrimack Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Merrimack Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Merrimack Pharmaceuticals' price. Additionally, you may evaluate how the addition of Merrimack Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| CEOs Directory Screen CEOs from public companies around the world | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins |
The data published in Merrimack Pharmaceuticals' official financial statements usually reflect Merrimack Pharmaceuticals' business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Merrimack Pharmaceuticals. For example, before you start analyzing numbers published by Merrimack accountants, it's critical to develop an understanding of what Merrimack Pharmaceuticals' liquidity, profitability, and earnings quality are in the context of the Biotechnology space in which it operates.
Please note, the presentation of Merrimack Pharmaceuticals' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Merrimack Pharmaceuticals' management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Merrimack Pharmaceuticals' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Merrimack Pharmaceuticals. Please utilize our Beneish M Score to check the likelihood of Merrimack Pharmaceuticals' management manipulating its earnings.